-
公开(公告)号:US12241900B2
公开(公告)日:2025-03-04
申请号:US18432995
申请日:2024-02-05
Applicant: IDEXX LABORATORIES, INC.
Abstract: This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.
-
公开(公告)号:US11933792B2
公开(公告)日:2024-03-19
申请号:US17815765
申请日:2022-07-28
Applicant: IDEXX LABORATORIES, INC.
CPC classification number: G01N33/6893 , G01N33/5308 , G01N33/92 , G01N2800/347 , G01N2800/60
Abstract: This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.
-